PL1886169T5 - Urządzenia okulistyczne do przedłużonego uwalniania związków czynnych - Google Patents

Urządzenia okulistyczne do przedłużonego uwalniania związków czynnych

Info

Publication number
PL1886169T5
PL1886169T5 PL06742806T PL06742806T PL1886169T5 PL 1886169 T5 PL1886169 T5 PL 1886169T5 PL 06742806 T PL06742806 T PL 06742806T PL 06742806 T PL06742806 T PL 06742806T PL 1886169 T5 PL1886169 T5 PL 1886169T5
Authority
PL
Poland
Prior art keywords
active compounds
sustained delivery
ophthalmic devices
ophthalmic
sustained
Prior art date
Application number
PL06742806T
Other languages
English (en)
Polish (pl)
Other versions
PL1886169T3 (pl
Inventor
Lynn Cook Winterton
John Martin Lally
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37027620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1886169(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL1886169T3 publication Critical patent/PL1886169T3/pl
Publication of PL1886169T5 publication Critical patent/PL1886169T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D11/00—Producing optical elements, e.g. lenses or prisms
    • B29D11/00009—Production of simple or compound lenses
    • B29D11/00038—Production of contact lenses
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
    • B29D11/00—Producing optical elements, e.g. lenses or prisms
    • B29D11/00865—Applying coatings; tinting; colouring
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
    • G02B1/041—Lenses
    • G02B1/043—Contact lenses

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physics & Mathematics (AREA)
  • Mechanical Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • General Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Eyeglasses (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL06742806T 2005-05-05 2006-05-04 Urządzenia okulistyczne do przedłużonego uwalniania związków czynnych PL1886169T5 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US67796405P 2005-05-05 2005-05-05
US71987805P 2005-09-23 2005-09-23
PCT/EP2006/004193 WO2006117228A2 (en) 2005-05-05 2006-05-04 Ophthalmic devices for sustained delivery of active compounds
EP06742806.0A EP1886169B2 (en) 2005-05-05 2006-05-04 Ophthalmic devices for sustained delivery of active compounds

Publications (2)

Publication Number Publication Date
PL1886169T3 PL1886169T3 (pl) 2011-05-31
PL1886169T5 true PL1886169T5 (pl) 2016-05-31

Family

ID=37027620

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06742806T PL1886169T5 (pl) 2005-05-05 2006-05-04 Urządzenia okulistyczne do przedłużonego uwalniania związków czynnych

Country Status (19)

Country Link
US (2) US9804295B2 (enExample)
EP (1) EP1886169B2 (enExample)
JP (1) JP5053261B2 (enExample)
CN (1) CN101171531B (enExample)
AR (1) AR055931A1 (enExample)
AT (1) ATE493679T2 (enExample)
AU (1) AU2006243345B2 (enExample)
BR (1) BRPI0611434A2 (enExample)
CA (1) CA2606073C (enExample)
DE (1) DE602006019234D1 (enExample)
DK (1) DK1886169T4 (enExample)
ES (1) ES2357623T5 (enExample)
MX (1) MX2007013739A (enExample)
NO (1) NO340948B1 (enExample)
PL (1) PL1886169T5 (enExample)
PT (1) PT1886169E (enExample)
TW (1) TWI375571B (enExample)
WO (1) WO2006117228A2 (enExample)
ZA (1) ZA200708953B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2824301C (en) 2005-11-25 2016-01-12 Novartis Ag F, g, h, i and k crystal forms of imatinib mesylate
BRPI0718543A2 (pt) * 2006-11-06 2013-11-12 Novartis Ag Dispositivos oculares e métodos de fabricação e uso dos mesmos
US20080152540A1 (en) * 2006-12-22 2008-06-26 Bausch & Lomb Incorporated Packaging solutions
JP5643092B2 (ja) 2007-08-31 2014-12-17 ノバルティス アーゲー コンタクトレンズのパッケージング溶液
TWI551305B (zh) 2007-08-31 2016-10-01 諾華公司 相對黏稠封裝溶液之用途
US20090182068A1 (en) * 2008-01-14 2009-07-16 Yuwen Liu Polymerizable Contact Lens Formulations and Contact Lenses Obtained Therefrom
JP4869274B2 (ja) * 2008-03-21 2012-02-08 株式会社メニコン ソフトコンタクトレンズ包装製品及びソフトコンタクトレンズの包装方法
EP2307189B1 (en) 2008-07-21 2014-06-04 Novartis AG Silicone hydrogel contact lenses with convertible comfort agents
US20100106128A1 (en) * 2008-10-23 2010-04-29 Shane Mao Contact lens cases for delivery of ophthalmic agents
TWI506333B (zh) * 2008-12-05 2015-11-01 Novartis Ag 用以傳遞疏水性舒適劑之眼用裝置及其製造方法
AU2012268828B2 (en) * 2008-12-05 2013-09-05 Alcon Inc. Ophthalmic devices for delivery of hydrophobic comfort agents
EP2962682B1 (en) * 2008-12-11 2018-03-28 Massachusetts Institute Of Technology Method of making a contact lens drug delivery device
CA2753106C (en) * 2009-02-20 2016-09-13 Seed Co., Ltd. Hydrogel contact lens for sustained drug release and drug release method using hydrogel contact lens for sustained drug release
ES2634551T3 (es) * 2010-04-03 2017-09-28 Praful Doshi Métodos para revestir una lente de contacto
SG187082A1 (en) 2010-07-30 2013-02-28 Coopervision Int Holding Co Lp Ophthalmic device molds formed from vinyl alcohol copolymer, ophthalmic devices molded therein, and related methods
SG194955A1 (en) 2011-06-09 2013-12-30 Novartis Ag Silicone hydrogel lenses with nano-textured surfaces
EP2793851B1 (en) 2011-12-21 2016-04-27 Novartis AG Contact lenses containing carotenoid and method for making same
US9351827B2 (en) * 2012-04-03 2016-05-31 Johnson & Johnson Vision Care, Inc. Lens driver for variable-optic electronic ophthalmic lens
US9827250B2 (en) * 2012-07-31 2017-11-28 Johnson & Johnson Vision Care, Inc. Lens incorporating myopia control optics and muscarinic agents
EP3233450B1 (en) 2014-12-17 2019-01-30 Novartis AG Reusable lens molds and methods of use thereof
WO2016100457A1 (en) 2014-12-17 2016-06-23 Novartis Ag Reusable lens molds and methods of use thereof
MY186090A (en) 2015-12-03 2021-06-21 Alcon Inc Contact lens packaging solutions
HUE063934T2 (hu) 2015-12-17 2024-02-28 Alcon Inc Újrahasználható lencseszerszámok, valamint eljárások azok használatára
US20180092776A1 (en) 2016-09-30 2018-04-05 Sara Heikali Method and device for treating and managing diseased ocular tissue
AU2018314280B2 (en) 2017-08-11 2023-07-20 Rsem, Société En Commandite Treatment of ophthalmic conditions such as macular degeneration, glaucoma, and diabetic retinopathy using pharmaceutical agents that eliminate senescent cells
JP7518773B2 (ja) * 2019-02-12 2024-07-18 株式会社クラレ ポリマー組成物、ゲル、フィルムおよび粒子
JP7704740B2 (ja) 2019-09-16 2025-07-08 アムジエン・インコーポレーテツド 薬物送達デバイスの外部滅菌の方法
KR20220034199A (ko) * 2019-09-18 2022-03-17 알콘 인코포레이티드 습식-패킹 소프트 하이드로겔 안구 삽입물
JP7564197B2 (ja) 2019-11-04 2024-10-08 アルコン インク． 異なる柔軟性を有する表面を有するコンタクトレンズ
CN111116798B (zh) * 2019-12-24 2021-07-23 中国科学院广州能源研究所 一种改性的天然气水合物动力学抑制剂
US12358247B2 (en) 2020-07-28 2025-07-15 Alcon Inc. Contact lenses with softer lens surfaces
US20240092043A1 (en) 2022-08-17 2024-03-21 Alcon Inc. Contact lens with a hydrogel coating thereon

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL128305C (enExample) 1963-09-11
DE2839249A1 (de) 1977-09-12 1979-03-22 Toray Industries Verfahren zur herstellung einer weichen kontaktlinse und ausgangsloesung zur durchfuehrung des verfahrens
JPS5590928A (en) * 1978-12-29 1980-07-10 Olympus Optical Co Ltd Endoscope objective lens which performs changing of magnification and focusing simultaneously
US4312575A (en) 1979-09-18 1982-01-26 Peyman Gholam A Soft corneal contact lens with tightly cross-linked polymer coating and method of making same
US4444711A (en) 1981-12-21 1984-04-24 Husky Injection Molding Systems Ltd. Method of operating a two-shot injection-molding machine
US4460534A (en) 1982-09-07 1984-07-17 International Business Machines Corporation Two-shot injection molding
US4625007A (en) 1982-09-30 1986-11-25 Polymer Technology Corporation Silicone-containing contact lens material and contact lenses made thereof
US5266563A (en) * 1984-06-11 1993-11-30 Biomatrix, Inc. Hyakyribate-poly (ethylene oxide) mixtures
US4713244A (en) 1985-08-16 1987-12-15 Bausch & Lomb Incorporated Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent
US4883658A (en) 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4744980A (en) 1986-04-28 1988-05-17 Holly Frank J Ophthalmic solution for treatment of dry eye syndrome
US4910277A (en) 1988-02-09 1990-03-20 Bambury Ronald E Hydrophilic oxygen permeable polymers
US4810764A (en) 1988-02-09 1989-03-07 Bausch & Lomb Incorporated Polymeric materials with high oxygen permeability and low protein substantivity
US5177165A (en) 1990-11-27 1993-01-05 Bausch & Lomb Incorporated Surface-active macromonomers
EP0603268B1 (en) 1991-09-12 1996-12-18 BAUSCH & LOMB INCORPORATED Wettable silicone hydrogel compositions and methods
US5573934A (en) * 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
AU5092493A (en) 1992-09-08 1994-03-29 Allergan, Inc. Sustained release of ophthalmic drugs from a soluble polymer drug delivery vehicle
US6800225B1 (en) 1994-07-14 2004-10-05 Novartis Ag Process and device for the manufacture of mouldings and mouldings manufactured in accordance with that process
EP0637491B1 (de) 1993-07-29 1997-11-05 Novartis AG Verfahren und Vorrichtung zur Herstellung von Formkörpern
TW272976B (enExample) * 1993-08-06 1996-03-21 Ciba Geigy Ag
EP0655470B1 (de) 1993-11-26 1999-05-12 Novartis AG Vernetzbare Copolymere und Hydrogele
US5712356A (en) 1993-11-26 1998-01-27 Ciba Vision Corporation Cross-linkable copolymers and hydrogels
US5894002A (en) 1993-12-13 1999-04-13 Ciba Vision Corporation Process and apparatus for the manufacture of a contact lens
US5843346A (en) 1994-06-30 1998-12-01 Polymer Technology Corporation Method of cast molding contact lenses
US6407145B1 (en) 1994-08-04 2002-06-18 Novartis Ag Photocrosslinkable materials and applications
US5665840A (en) 1994-11-18 1997-09-09 Novartis Corporation Polymeric networks from water-soluble prepolymers
EP0712867B1 (de) 1994-11-18 1999-07-14 Novartis AG Polymere Netzwerke aus wasserlöslichen Präpolymeren
MX9705867A (es) 1995-02-03 1997-12-31 Novartis Ag Polimeros reticulados que contienen fotoiniciadores.
TW349967B (en) 1995-02-03 1999-01-11 Novartis Ag Process for producing contact lenses and a cross-linkable polyvinylalcohol used therefor
AU4438696A (en) 1995-02-03 1996-08-21 Novartis Ag Crosslinked polymers
WO1996024075A1 (en) 1995-02-03 1996-08-08 Novartis Ag Crosslinked polymers containing ester or amide groups
US5583463A (en) 1995-05-30 1996-12-10 Micron Technology, Inc. Redundant row fuse bank circuit
DE69625658T2 (de) * 1995-09-13 2003-07-17 Seikagaku Kogyo K.K.(Seikagaku Corp.), Tokio/Tokyo Kontaktlinse auf Basis photogehärteter Hyaluronsäure
WO1998017704A1 (en) 1996-10-21 1998-04-30 Novartis Ag Crosslinkable polymers
EP0867456A1 (de) 1997-02-04 1998-09-30 Novartis AG Ophthalmischer Formkörper
TW425403B (en) 1997-02-04 2001-03-11 Novartis Ag Branched polyurethane (meth)acrylate prepolymers, opthal-mic mouldings derived therefrom and processes for their manufacture
ES2175698T3 (es) 1997-02-21 2002-11-16 Novartis Ag Articulos de moldeo oftalmicos.
GB9711818D0 (en) 1997-06-06 1997-08-06 Bausch & Lomb Contact lens packing solutions and methods for improving the comfort of disposable contact lenses
WO1999011692A1 (en) 1997-09-03 1999-03-11 The Regents Of The University Of California Novel biomimetic hydrogel materials
JP4616473B2 (ja) 1997-09-16 2011-01-19 ノバルティス アーゲー 架橋結合可能なポリ尿素ポリマー類
TW429327B (en) 1997-10-21 2001-04-11 Novartis Ag Single mould alignment
US6367929B1 (en) 1998-03-02 2002-04-09 Johnson & Johnson Vision Care, Inc. Hydrogel with internal wetting agent
US6943203B2 (en) 1998-03-02 2005-09-13 Johnson & Johnson Vision Care, Inc. Soft contact lenses
US6822016B2 (en) 2001-09-10 2004-11-23 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US7052131B2 (en) 2001-09-10 2006-05-30 J&J Vision Care, Inc. Biomedical devices containing internal wetting agents
US6039913A (en) 1998-08-27 2000-03-21 Novartis Ag Process for the manufacture of an ophthalmic molding
EP1002807A1 (en) 1998-11-20 2000-05-24 Novartis AG Functionalized resin derived from polyallylamine
JP5242876B2 (ja) 2000-03-24 2013-07-24 ノバルティス アーゲー 架橋結合性または重合性プレポリマー
US6811805B2 (en) 2001-05-30 2004-11-02 Novatis Ag Method for applying a coating
JP2003033454A (ja) 2001-07-23 2003-02-04 Endo Mfg Co Ltd ゴルフクラブヘッドの製造方法
TWI255224B (en) * 2002-01-09 2006-05-21 Novartis Ag Polymeric articles having a lubricious coating and method for making the same
WO2004016671A1 (en) 2002-08-14 2004-02-26 Novartis Ag Radiation-curable prepolymers
US7235195B2 (en) * 2002-09-06 2007-06-26 Novartis Ag Method for making opthalmic devices
US20040116564A1 (en) 2002-11-27 2004-06-17 Devlin Brian Gerrard Stabilization of poly(oxyalkylene) containing polymeric materials
US20040115270A1 (en) 2002-12-13 2004-06-17 Dharmendra Jani Absorption and controlled release of polyethers from hydrogel biomaterials
US7387759B2 (en) 2002-12-17 2008-06-17 Novartis Ag System and method for curing polymeric moldings having a masking collar
US7384590B2 (en) 2002-12-17 2008-06-10 Novartis Ag System and method for curing polymeric moldings
US20040119176A1 (en) 2002-12-23 2004-06-24 Bausch & Lomb Incorporated Method for manufacturing lenses
US20040214914A1 (en) 2003-04-24 2004-10-28 Ocular Sciences, Inc. Hydrogel contact lenses and package systems and production methods for same
US7977430B2 (en) 2003-11-25 2011-07-12 Novartis Ag Crosslinkable polyurea prepolymers
US7786185B2 (en) 2004-03-05 2010-08-31 Johnson & Johnson Vision Care, Inc. Wettable hydrogels comprising acyclic polyamides
US7249848B2 (en) 2004-09-30 2007-07-31 Johnson & Johnson Vision Care, Inc. Wettable hydrogels comprising reactive, hydrophilic, polymeric internal wetting agents

Also Published As

Publication number Publication date
BRPI0611434A2 (pt) 2010-09-08
CN101171531A (zh) 2008-04-30
CN101171531B (zh) 2010-06-16
MX2007013739A (es) 2008-01-21
DK1886169T4 (en) 2016-03-14
AR055931A1 (es) 2007-09-12
ZA200708953B (en) 2008-06-25
WO2006117228A2 (en) 2006-11-09
ES2357623T5 (es) 2016-03-29
PL1886169T3 (pl) 2011-05-31
EP1886169B2 (en) 2015-12-09
EP1886169B1 (en) 2010-12-29
US20060251696A1 (en) 2006-11-09
CA2606073C (en) 2013-12-03
AU2006243345A1 (en) 2006-11-09
AU2006243345B2 (en) 2010-03-18
DE602006019234D1 (de) 2011-02-10
TW200716201A (en) 2007-05-01
US9804295B2 (en) 2017-10-31
WO2006117228A3 (en) 2007-02-01
JP5053261B2 (ja) 2012-10-17
DK1886169T3 (da) 2011-03-14
JP2008539837A (ja) 2008-11-20
CA2606073A1 (en) 2006-11-09
TWI375571B (en) 2012-11-01
ES2357623T3 (es) 2011-04-28
EP1886169A2 (en) 2008-02-13
PT1886169E (pt) 2011-03-07
NO340948B1 (no) 2017-07-24
US20170307780A1 (en) 2017-10-26
NO20076252L (no) 2008-02-05
ATE493679T2 (de) 2011-01-15

Similar Documents

Publication Publication Date Title
ZA200708953B (en) Ophthalmic devices for sustained delivery of active compounds
PL2058020T3 (pl) Urządzenie do podawania leków
IL185250A0 (en) Microimplants for ocular administration
IL208947A0 (en) Ophthalmic devices for the controlled release of active agents
PL2213168T3 (pl) Pestycydowe kombinacje substancji czynnych
ZA200710734B (en) Compositions for drug delivery
IL185889A0 (en) Dispenser for delivering medicament
SG138565A1 (en) Punctal plugs for the delivery of active agents
PL2154968T3 (pl) Kombinacje grzybobójczych substancji czynnych
SG138567A1 (en) Punctal plugs for the delivery of active agents
GB0524961D0 (en) Transdermal administration of active agents for systemic effect
GB0524958D0 (en) Transdermal administration of active agents
GB0402492D0 (en) Pharmaceutically active compounds
ZA200804952B (en) Fungicidal active substance combination
EP1776112A4 (en) HETEROCYCLIC COMPOUNDS AS PHARMACEUTICAL AGENTS
EP1852106A4 (en) SOLID OPHTHALMIC MEDICINE FOR EXTERNAL USE
EP1858522A4 (en) PHARMACEUTICALLY ACCEPTABLE CARRIER FOR OPHTHALMIC COMPOSITIONS
SG138564A1 (en) Punctal plugs for the delivery of active agents
EP1859795A4 (en) THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES
GB0517838D0 (en) Transdermal active principle delivery means
HK1147205A (en) Delivery of active agents
IL190319A0 (en) Nanoparticles for targeted delivery of active agents
GB0610207D0 (en) New forms of active pharmaceutical ingredient
HK1129828A (en) Punctal plugs for the delivery of active agents
HK1128401A (en) Punctal plugs for the delivery of active agents